Literature DB >> 24715274

[Acquired bleeding disorders - diagnostic approach].

R Klamroth1.   

Abstract

BACKGROUND: Patients with acquired bleeding disorders are often a diagnostic challenge in internal medicine.
OBJECTIVES: Which diagnostic work up is necessary in these patients and which coagulation tests are useful?
MATERIAL AND METHODS: Analysis and diagnostic workup in the daily practice are discussed according to review publications in this field and existing clinical evidence.
RESULTS: First important step is the bleeding history of the patient. The different signs of bleeding are important hints for the cause. The global assays Quick (PT) and PTT in combination with platelet count and function reveal a primary knowledge of the kind of the acquired bleeding disorder. In addition special coagulation tests normally lead to the exact diagnosis of the cause of bleeding.
CONCLUSIONS: Patients with newly developed bleeding symptoms should be examined for acquired coagulation disorders. The clinical sings in combination with the special coagulation tests allow the correct diagnosis.

Entities:  

Mesh:

Year:  2014        PMID: 24715274     DOI: 10.1007/s00108-013-3421-6

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  15 in total

Review 1.  Acquired haemophilia: review and meta-analysis focused on therapy and prognostic factors.

Authors:  Julio Delgado; Victor Jimenez-Yuste; Fernando Hernandez-Navarro; Ana Villar
Journal:  Br J Haematol       Date:  2003-04       Impact factor: 6.998

Review 2.  [Diagnostic of blood coagulation].

Authors:  M Barthels
Journal:  Hamostaseologie       Date:  2008-12       Impact factor: 1.778

Review 3.  [Acquired coagulopathies].

Authors:  H Riess
Journal:  Hamostaseologie       Date:  2008-12       Impact factor: 1.778

4.  Can the Platelet Function Analyzer (PFA)-100 test substitute for the template bleeding time in routine clinical practice?

Authors:  J Francis; D Francis; L Larson; E Helms; M Garcia
Journal:  Platelets       Date:  1999       Impact factor: 3.862

5.  Prospective evaluation of the clinical utility of quantitative bleeding severity assessment in patients referred for hemostatic evaluation.

Authors:  A Tosetto; G Castaman; I Plug; F Rodeghiero; J Eikenboom
Journal:  J Thromb Haemost       Date:  2011-06       Impact factor: 5.824

Review 6.  [Differential diagnosis and treatment of thrombocytopenia].

Authors:  V Kiefel; A Greinacher
Journal:  Internist (Berl)       Date:  2010-11       Impact factor: 0.743

7.  A practical concept for preoperative identification of patients with impaired primary hemostasis.

Authors:  Juergen Koscielny; Sabine Ziemer; Hartmut Radtke; Michael Schmutzler; Axel Pruss; Pranav Sinha; Abdulgabar Salama; Holger Kiesewetter; Reinhard Latza
Journal:  Clin Appl Thromb Hemost       Date:  2004-07       Impact factor: 2.389

Review 8.  [Inborn and acquired von Willebrand disease].

Authors:  R Schneppenheim; U Budde
Journal:  Hamostaseologie       Date:  2008-12       Impact factor: 1.778

Review 9.  [Acquired platelet function disorders: pathogenesis, classification, frequency, diagnosis, clinical management].

Authors:  R E Scharf
Journal:  Hamostaseologie       Date:  2008-12       Impact factor: 1.778

Review 10.  Activated factor VII activates factors IX and X on the surface of activated platelets: thoughts on the mechanism of action of high-dose activated factor VII.

Authors:  M Hoffman; D M Monroe; H R Roberts
Journal:  Blood Coagul Fibrinolysis       Date:  1998-03       Impact factor: 1.276

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.